Surprising similarities between human and zebrafish tumors
New finding that tumor cells in both species have too many chromosomes could help pinpoint genes that drive cancer development.
Search Stories
Why telecom regulation needs to change
Research suggests that the approach that worked with a few large companies with aligned interests needs revisiting in the Internet age.
New nanoparticles could improve cancer treatment
Particles can deliver a combination of chemotherapy drugs directly to prostate-cancer cells.
Beyond the bubble
At Center for Real Estate conference, economists contemplate ways to make the risks of financial innovation more evident.
Your vital signs, on camera
MIT team develops system for continuous medical monitoring using widely available video technology.
President Hockfield reports steady progress at annual State of the Institute forum
MIT looks to the future after two years of budget cuts.
Putting heads together
New study: groups demonstrate distinctive ‘collective intelligence’ when facing difficult tasks
Getting bacteria to do a plant’s job
Researchers engineer microbes for low-cost production of precursor of anticancer drug Taxol and other pharmaceuticals.
5 from MIT win NIH awards
The grants are designed to promote risky, innovative research with the potential to transform a field of study.
Multicore may not be so scary
Research suggests that the free operating system Linux will keep up with the addition of more ‘cores,’ or processing units, to computer chips.
Better prepared next time
Lessons learned from the BP oil spill could help both companies and regulators to be more ready for the next emergency.
Making stem-cell therapy a reality
In Killian Award lecture, Rudolf Jaenisch outlines progress and possibilities for treating human disease with stem cells.
A step closer to Big Bang conditions?
More study is needed to confirm the latest findings from the Large Hadron Collider, reported by CERN physicists last week.
Explained: Defining recessions
It’s not what conventional wisdom holds, as an MIT economist — who heads the bureau charged with identifying U.S. downturns — makes clear.